Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Radiotherapy prolongs biliary metal stent patency in malignant pancreatobiliary obstructions.

Park S, Park JY, Bang S, Park SW, Chung JB, Song SY.

Gut Liver. 2013 Jul;7(4):480-5. doi: 10.5009/gnl.2013.7.4.480. Epub 2013 Jun 11.

2.

Expandable metal biliary stenting in patients with recurrent premature polyethylene stent occlusion.

Menon K, Romagnuolo J, Barkun AN.

Am J Gastroenterol. 2001 May;96(5):1435-40.

PMID:
11374679
3.

Adjuvant therapies using biliary stenting for malignant biliary obstruction.

Miura Y, Endo I, Togo S, Sekido H, Misuta K, Fujii Y, Kubota T, Tanaka K, Nagahori K, Shimada H.

J Hepatobiliary Pancreat Surg. 2001;8(2):113-7.

PMID:
11455465
4.

Nintinol self-expandable metallic stenting in management of malignant obstructive jaundice: a case series.

Ghanaati H, Firouznia K, Vaziri Bozorg SM, Ghasemi Esfe AR, Motevallei M, Abedini MR, Sadeghi SR.

Hepat Mon. 2010 Winter;10(1):57-61. Epub 2010 Mar 1.

5.

Long-term clinical outcomes of self-expanding metal stents for treatment of malignant gastroesophageal junction obstructions and prognostic factors for stent patency: effects of anticancer treatments.

Park JJ, Lee YC, Kim BK, Kim JH, Park JC, Kim YJ, Lee SK, Song SY, Chung JB.

Dig Liver Dis. 2010 Jun;42(6):436-40. doi: 10.1016/j.dld.2009.07.020. Epub 2009 Sep 19.

PMID:
19767253
6.

Preliminary results of a new covered biliary metal stent for malignant biliary obstruction.

Shim CS, Lee YH, Cho YD, Bong HK, Kim JO, Cho JY, Kim YS, Lee JS, Lee MS, Hwang SG, Shin KM.

Endoscopy. 1998 May;30(4):345-50.

PMID:
9689506
7.

Endoscopic management of malignant biliary obstruction by means of covered metallic stents: primary stent placement vs. re-intervention.

Kida M, Miyazawa S, Iwai T, Ikeda H, Takezawa M, Kikuchi H, Watanabe M, Imaizumi H, Koizumi W.

Endoscopy. 2011 Dec;43(12):1039-44. doi: 10.1055/s-0030-1256769. Epub 2011 Oct 4.

PMID:
21971926
8.

Percutaneous trans-hepatic bilateral biliary stenting in Bismuth IV malignant obstruction.

Karnabatidis D, Spiliopoulos S, Katsakiori P, Romanos O, Katsanos K, Siablis D.

World J Hepatol. 2013 Mar 27;5(3):114-9. doi: 10.4254/wjh.v5.i3.114.

9.

Effectiveness of the Ultraflex Diamond stent for the palliation of malignant biliary obstruction.

Ahmad J, Siqueira E, Martin J, Slivka A.

Endoscopy. 2002 Oct;34(10):793-6.

PMID:
12244500
10.

Clinical outcome of simultaneous self-expandable metal stents for palliation of malignant biliary and duodenal obstruction.

Kaw M, Singh S, Gagneja H.

Surg Endosc. 2003 Mar;17(3):457-61. Epub 2002 Oct 31.

PMID:
12404053
11.

Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative study.

Jang SI, Kim JH, You JW, Rhee K, Lee SJ, Kim HG, Han J, Shin IH, Park SH, Lee DK.

Dig Dis Sci. 2013 Mar;58(3):865-71. doi: 10.1007/s10620-012-2472-1. Epub 2012 Nov 21.

PMID:
23179148
12.

Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas.

Maire F, Hammel P, Ponsot P, Aubert A, O'Toole D, Hentic O, Levy P, Ruszniewski P.

Am J Gastroenterol. 2006 Apr;101(4):735-42.

PMID:
16635221
13.

Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction.

Naitoh I, Ohara H, Nakazawa T, Ando T, Hayashi K, Okumura F, Okayama Y, Sano H, Kitajima Y, Hirai M, Ban T, Miyabe K, Ueno K, Yamashita H, Joh T.

J Gastroenterol Hepatol. 2009 Apr;24(4):552-7. doi: 10.1111/j.1440-1746.2008.05750.x. Epub 2009 Feb 12.

PMID:
19220678
14.

Metallic stents in malignant biliary obstruction: prospective long-term clinical results.

Lee BH, Choe DH, Lee JH, Kim KH, Chin SY.

AJR Am J Roentgenol. 1997 Mar;168(3):741-5.

PMID:
9057527
15.

Percutaneous placement of metallic stents in the management of malignant biliary obstruction.

Chiou YY, Tseng HS, Chiang JH, Hwang JI, Chou YH, Chang CY.

J Formos Med Assoc. 2005 Oct;104(10):738-43.

PMID:
16385376
16.

Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction.

Saleem A, Leggett CL, Murad MH, Baron TH.

Gastrointest Endosc. 2011 Aug;74(2):321-327.e1-3. doi: 10.1016/j.gie.2011.03.1249. Epub 2011 Jun 17.

PMID:
21683354
17.

Partially covered self-expanding metal stent for unresectable malignant extrahepatic biliary obstruction: results of a large prospective series.

Gómez-Oliva C, Guarner-Argente C, Concepción M, Jiménez FJ, Rodríguez S, Gonzalez-Huix F, Mugica F, Cabriada JL, Rodríguez C, Aguilar CG; Collaborating Group of the COBIWA Register.

Surg Endosc. 2012 Jan;26(1):222-9. doi: 10.1007/s00464-011-1858-z. Epub 2011 Aug 20.

PMID:
21858574
18.

Stent patency using competing risk model in unresectable pancreatic cancers inserted with biliary self-expandable metallic stent.

Eum YO, Kim YT, Lee SH, Park SW, Hwang JH, Yoon WJ, Ryu JK, Yoon YB, Han JK, Yoon CJ, Cho JH, Choi Y.

Dig Endosc. 2013 Jan;25(1):67-75. doi: 10.1111/j.1443-1661.2012.01335.x. Epub 2012 Jun 11.

PMID:
23286259
19.

Endoscopic management of occluded biliary Wallstents: a cancer center experience.

Bueno JT, Gerdes H, Kurtz RC.

Gastrointest Endosc. 2003 Dec;58(6):879-84.

PMID:
14652557
20.

Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study.

Singh V, Kapoor R, Solanki KK, Singh G, Verma GR, Sharma SC.

Liver Int. 2007 Apr;27(3):347-52.

PMID:
17355456
Items per page

Supplemental Content

Write to the Help Desk